Matches in Wikidata for { <http://www.wikidata.org/entity/Q64149799> ?p ?o ?g. }
Showing items 1 to 48 of
48
with 100 items per page.
- Q64149799 description "clinical trial" @default.
- Q64149799 description "ensayu clínicu" @default.
- Q64149799 description "klinisch onderzoek" @default.
- Q64149799 description "клінічне випробування" @default.
- Q64149799 name "LIBERTY EXTENSION: Efficacy and Safety Extension Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids" @default.
- Q64149799 type Item @default.
- Q64149799 label "LIBERTY EXTENSION: Efficacy and Safety Extension Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids" @default.
- Q64149799 prefLabel "LIBERTY EXTENSION: Efficacy and Safety Extension Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids" @default.
- Q64149799 P1050 Q64149799-50803780-D1A9-4DCD-BBAD-2A196B6256CD @default.
- Q64149799 P1050 Q64149799-AB88F2B5-DCE2-4AB0-9E32-8B6193FA0CB3 @default.
- Q64149799 P1132 Q64149799-E3EF5CFE-EC75-41B5-B25E-34DE24672414 @default.
- Q64149799 P1476 Q64149799-F3BDA258-E8A9-483E-8101-8334CF70585B @default.
- Q64149799 P17 Q64149799-15EAAB5E-FF24-47D3-A12B-186A588CD9EC @default.
- Q64149799 P17 Q64149799-1996D39F-45BA-4E7E-8AC0-BA8131BCDE3B @default.
- Q64149799 P17 Q64149799-283E3E64-3A04-4CCB-BAE0-728955F9A3A9 @default.
- Q64149799 P17 Q64149799-63059809-49BB-48A7-8768-E2FE72795E22 @default.
- Q64149799 P17 Q64149799-866B4296-CD64-46EC-9AFC-BB91CE544D90 @default.
- Q64149799 P17 Q64149799-94580F71-39B4-4291-9B24-CD590B59F258 @default.
- Q64149799 P17 Q64149799-9689E77B-C40F-409F-8C11-FBC06BC04EA9 @default.
- Q64149799 P17 Q64149799-AD3581C2-ABDB-41DB-949E-FDCE50CB6E05 @default.
- Q64149799 P2899 Q64149799-32F7D137-AEF8-4517-962D-C53D71EED8F5 @default.
- Q64149799 P3098 Q64149799-56E90666-A652-4E7D-9CDD-8F476D45CEE8 @default.
- Q64149799 P31 Q64149799-1D33F32B-8E0C-49A2-BB79-7B450FC5134F @default.
- Q64149799 P4135 Q64149799-3EB5E95B-31F0-4671-8076-FF7EB5A85920 @default.
- Q64149799 P580 Q64149799-5E01F13C-A384-441E-BA10-99768F5EB7EC @default.
- Q64149799 P582 Q64149799-B552A0F7-4784-43E8-830D-636C5F8B8945 @default.
- Q64149799 P6099 Q64149799-41ACE499-0EC7-4C43-9E7E-E273BDC22947 @default.
- Q64149799 P8363 Q64149799-6A3921B2-E331-42FB-8F5D-189EB74716CA @default.
- Q64149799 P1050 Q18556303 @default.
- Q64149799 P1050 Q4667534 @default.
- Q64149799 P1132 "+600" @default.
- Q64149799 P1476 "LIBERTY EXTENSION: An International Phase 3 Open-Label, Single-Arm, Long-Term Efficacy and Safety Extension Study to Evaluate Relugolix Co-Administered With Low-Dose Estradiol and Norethindrone Acetate in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids" @default.
- Q64149799 P17 Q155 @default.
- Q64149799 P17 Q258 @default.
- Q64149799 P17 Q28 @default.
- Q64149799 P17 Q298 @default.
- Q64149799 P17 Q30 @default.
- Q64149799 P17 Q31 @default.
- Q64149799 P17 Q36 @default.
- Q64149799 P17 Q38 @default.
- Q64149799 P2899 "+18" @default.
- Q64149799 P3098 "NCT03412890" @default.
- Q64149799 P31 Q30612 @default.
- Q64149799 P4135 "+50" @default.
- Q64149799 P580 "2017-10-19T00:00:00Z" @default.
- Q64149799 P582 "2020-02-28T00:00:00Z" @default.
- Q64149799 P6099 Q42824827 @default.
- Q64149799 P8363 Q78089383 @default.